Literature DB >> 26495850

Correction: Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.

.   

Abstract

Entities:  

Year:  2015        PMID： 26495850      PMCID： PMC4619721          DOI： 10.1371/journal.pone.0140921

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


× No keyword cloud information.
  1 in total

1.  Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.

Authors:  Alicia Romero-Lorca; Apolonia Novillo; María Gaibar; Fernando Bandrés; Ana Fernández-Santander
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240
  1 in total
  1 in total

1.  Tamoxifen-related endocrine symptoms in Chinese patients with breast cancer: Study protocol clinical trial (SPIRIT Compliant).

Authors:  Carmen Wing Han Chan; Christine Miaskowski; Alexandra McCarthy; Mary Miu Yee Waye; Winnie Yeo; Winnie Kwok Wai So; Kai Chow Choi; Stephen Kwok Wing Tsui; Judy Yuet Wa Chan
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.